Furthermore, a PET study showed lower availability of 5-HT1A receptors in patients with schizophrenia compared to healthy controls and receptor binding was negatively associated with negative symptoms, estimated by the PANSS scale [66]. Here, HTR1A is linked to schizophrenia.